Partner Liane Peterson was quoted in a Bloomberg Law article, “Rush for Generic Go-Ahead on Novel Drugs Roils Pharma Industry,” about the growth in the number of generic drugmakers seeking to bring competing versions of brand name products to market as quickly as possible.
Peterson said the trend has led to more smaller players jumping in to be first-filers on profitable drugs, which “would suggest the bigger players don’t want to share the market with anyone else.”
People
Related News
December 29, 2025
In the News
Matt Kiel Featured by Los Angeles Business Journal – 'Keep pressing forward and doing your best'
Foley & Lardner LLP senior counsel Matt Kiel is featured by Los Angeles Business Journal for his career journey in the article, “Matt Kiel's Steady Climb.”
December 26, 2025
In the News
Louis Lehot Shares 2026 M&A Outlook on Financing, Exits, and Key Trends
Foley & Lardner LLP partner Louis Lehot was featured in the Mergers & Acquisitions' week-long series, “The 2026 M&A Outlook.”
December 24, 2025
In the News
Kyle Faget on HHS Gender-Affirming Care Declaration – Impact is 'Enormous'
Foley & Lardner LLP partner Kyle Faget commented on the recent Department of Health and Human Services declaration rejecting gender-affirming care in the STAT News article, “Nineteen states, D.C. sue HHS over gender-affirming care crackdown."